Skip to main content

Table 3 Postprandial area under the curve data of pre-diabetic subjects before and after an eight week intervention of ALCA or placebo

From: Effect of oral acetyl L-carnitine arginate on resting and postprandial blood biomarkers in pre-diabetics

Variable

Pre Intervention ALCA

Post Intervention ALCA

Pre Intervention Placebo

Post Intervention Placebo

Malondialdehyde

(μmol·L-1·6 hr-1)

9.66 ± 1.33

9.39 ± 1.17

9.56 ± 1.15

9.26 ± 1.07

Xanthine Oxidase

(mU·mL-1·6 hr-1)

67.77 ± 7.70

67.45 ± 9.24

74.11 ± 8.58

76.91 ± 10.39

Hydrogen Peroxide

(μmol·L-1·6 hr-1)

84.76 ± 13.15

81.25 ± 14.87

79.65 ± 12.47

86.45 ± 15.43

Triglyceride

(mg·dL-1·6 hr-1)

585.00 ± 74.22

580.50 ± 73.84

612.95 ± 92.98

597.08 ± 70.43

Glucose

(mg·dL-1·6 hr-1)

658.00 ± 56.27

640.18 ± 73.71

683.00 ± 67.82

679.45 ± 54.46

TEAC

(mmol·L-1·6 hr-1)

3.30 ± 0.19

3.45 ± 0.18

3.25 ± 0.21

3.28 ± 0.19

Nitrate/Nitrite

(μmol·L-1·6 hr-1)

139.50 ± 18.35

172.40 ± 21.75

128.70 ± 11.75

130.45 ± 10.15

  1. Data are mean ± SEM.
  2. No statistically significant differences noted (p > 0.05).